SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on October 22, 2019, reporting events occurring on October 17, 2019. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The filing addresses corporate governance amendments rather than operational or financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding bylaw amendments and does not contain financial statements or operational metrics.
Material Changes
The material change reported is the adoption of the First Amendment to the Company's amended and restated bylaws, effective October 17, 2019. This amendment modifies Article III, Section 3.3 to define the term of office for directors. Under the new provision, each director shall hold office until the next annual meeting of stockholders and until their successor is elected and qualified, or until earlier death, resignation, or removal.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the amendment of corporate bylaws.
Investor Verification Checklist
- Verify the exact text of the First Amendment to the Bylaws attached as Exhibit 3.1.
- Confirm the impact of the new director term provisions on the company's governance structure.
- Note that this filing does not reflect financial performance; refer to the most recent 10-K or 10-Q for financial data.
- Confirm the company name is BioSig Technologies, Inc., as the input metadata referenced "Streamex Corp." which is incorrect based on the filing text.